Peripheral mechanisms of homeostasis and tolerance through skin dendritic cells
通过皮肤树突状细胞实现稳态和耐受的外周机制
基本信息
- 批准号:9258870
- 负责人:
- 金额:$ 40.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-19 至 2021-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAntigensAutoantigensAutoimmune DiseasesAutoimmunityB-LymphocytesBloodCancer VaccinesCellsClinicColorectal CancerCuesCutaneousCutaneous MelanomaDataDendritic CellsDendritic cell activationDepositionDetectionDevelopmentEmigrantFeedbackGene ExpressionGenesGeneticGlomerulonephritisGoalsGrowthHematopoieticHomeostasisHumanIFNGR1 geneImmuneImmune ToleranceImmune systemImmunityImmunologic SurveillanceImmunologyImmunotherapyIn SituIn VitroInflammationInflammatoryInterferon Type IILeadLeftLungLymphoid TissueMalignant NeoplasmsMalignant neoplasm of lungModalityModelingMusPDCD1LG1 genePathway interactionsPatientsPeripheralPopulationPropertyRegulationRegulatory T-LymphocyteReportingRoleScienceScreening for Skin CancerSeedsSelf ToleranceSentinelSkinSkin CancerSurveysT-LymphocyteTestingTherapeutic InterventionTissuesTranscriptTravelTumor Escapeabstractingadaptive immunitybasecell motilityconditioningdiphtheria toxin receptorimprovedin vivoin vivo Modellymph nodesmacrophagemonocytenovelperipheral toleranceprogramsskin disordertherapeutic targettooltraffickingtumortumor progression
项目摘要
Project Summary/Abstract
The immune system surveys the skin and other barrier tissues such as lung and gut, but
mechanisms for failed immunity in the periphery that lead to cancer or autoimmune diseases
are unknown. The dendritic cell (DC) is a specialized immune sentinel that directs T cells to
tolerance or immunity. DC comprise a rich network in skin consisting of several different
populations, but are understudied, leaving a major gap in therapeutic intervention. We have
identified distinct properties for DC in skin that relay information by migrating out to the draining
lymph node (LN). We find during inflammation skin migratory DC may direct T cells to tolerance
by unknown mechanisms, counter-regulating and controlling immunity. These cells are uniquely
genetically programed in humans and in mouse to dampen immunity with a high expression of
shared tolerance genes, including some genes such as PD-L1 that have been successfully
targeted in the clinic for peripheral tissue cancers including melanoma skin cancer, colorectal
cancer and lung cancer. We hypothesize homeostatic programming of skin DC leads to failed
immune priming leading to impaired early detection of skin cancers. We find these pathways are
of great importance as therapeutic targets to promote self-tolerance (such as during
autoimmune disease) or to block tolerance (to improve immunity during cancer). Because these
mechanisms are distinct they can be combined with current modalities for patients in
immunotherapy of skin cancer, vaccine science, and inflammatory skin disease. In 2 discrete
aims, this application will address programmatic conditioning of skin DCs and the unique cellular
mechanisms by which they promote immune tolerance in both mice and humans, examining
consequences during immune priming and early skin cancer growth.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Niroshana Anandasabapathy其他文献
Niroshana Anandasabapathy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Niroshana Anandasabapathy', 18)}}的其他基金
High-parametric flow cytometry cell sorter for human immunology studies.
用于人类免疫学研究的高参数流式细胞仪细胞分选仪。
- 批准号:
10632888 - 财政年份:2023
- 资助金额:
$ 40.96万 - 项目类别:
Interrogating unique DC adaptations to tissue to promote barrier immunity and tolerance
探究 DC 对组织的独特适应,以促进屏障免疫和耐受性
- 批准号:
10378337 - 财政年份:2022
- 资助金额:
$ 40.96万 - 项目类别:
Interrogating unique DC adaptations to tissue to promote barrier immunity and tolerance
探究 DC 对组织的独特适应,以促进屏障免疫和耐受性
- 批准号:
10579963 - 财政年份:2022
- 资助金额:
$ 40.96万 - 项目类别:
Peripheral mechanisms of homeostasis and tolerance through skin dendritic cells
通过皮肤树突状细胞实现稳态和耐受的外周机制
- 批准号:
9684364 - 财政年份:2018
- 资助金额:
$ 40.96万 - 项目类别:
Peripheral mechanisms of homeostasis and tolerance through skin dendritic cells
通过皮肤树突状细胞实现稳态和耐受的外周机制
- 批准号:
9768889 - 财政年份:2018
- 资助金额:
$ 40.96万 - 项目类别:
Peripheral mechanisms of homeostasis and tolerance through skin dendritic cells
通过皮肤树突状细胞实现稳态和耐受的外周机制
- 批准号:
10004498 - 财政年份:2018
- 资助金额:
$ 40.96万 - 项目类别:
Peripheral mechanisms of homeostasis and tolerance through skin dendritic cells
通过皮肤树突状细胞实现稳态和耐受的外周机制
- 批准号:
9397655 - 财政年份:2016
- 资助金额:
$ 40.96万 - 项目类别:
Peripheral mechanisms of homeostasis and tolerance through skin dendritic cells
通过皮肤树突状细胞实现稳态和耐受的外周机制
- 批准号:
9353720 - 财政年份:2016
- 资助金额:
$ 40.96万 - 项目类别:
The clinical use of Flt3L - an immune adjuvant to potentiate Dendritic Cells
Flt3L——增强树突状细胞免疫佐剂的临床应用
- 批准号:
8609183 - 财政年份:2012
- 资助金额:
$ 40.96万 - 项目类别:
The clinical use of Flt3L - an immune adjuvant to potentiate Dendritic Cells
Flt3L——增强树突状细胞免疫佐剂的临床应用
- 批准号:
9096028 - 财政年份:2012
- 资助金额:
$ 40.96万 - 项目类别:
相似国自然基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
- 批准号:2022J011295
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
- 批准号:30801055
- 批准年份:2008
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
- 批准号:
BB/Y006224/1 - 财政年份:2024
- 资助金额:
$ 40.96万 - 项目类别:
Research Grant
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
- 批准号:
480030 - 财政年份:2023
- 资助金额:
$ 40.96万 - 项目类别:
Operating Grants
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
- 批准号:
10083718 - 财政年份:2023
- 资助金额:
$ 40.96万 - 项目类别:
Small Business Research Initiative
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
- 批准号:
MR/X009254/1 - 财政年份:2023
- 资助金额:
$ 40.96万 - 项目类别:
Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
- 批准号:
22KJ1758 - 财政年份:2023
- 资助金额:
$ 40.96万 - 项目类别:
Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
- 批准号:
BB/Y000927/1 - 财政年份:2023
- 资助金额:
$ 40.96万 - 项目类别:
Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
- 批准号:
10795212 - 财政年份:2023
- 资助金额:
$ 40.96万 - 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
- 批准号:
23K18249 - 财政年份:2023
- 资助金额:
$ 40.96万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
- 批准号:
10645989 - 财政年份:2023
- 资助金额:
$ 40.96万 - 项目类别:
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
- 批准号:
10735075 - 财政年份:2023
- 资助金额:
$ 40.96万 - 项目类别: